Valeant Pharmaceuticals said it will acquire assets from Altantis Pharma, a branded generics pharmaceutical company, for about $71 million, in order to expand its reach in Mexico.
The specifics of the acquisition were not disclosed, but Valeant said that the acquired assets' total revenue in 2011 was...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?